nygazet.com logo
Oruka Therapeutics: How This Small Name Is Rivaling AbbVie's $18 Billion Franchise
business

Oruka Therapeutics: How This Small Name Is Rivaling AbbVie's $18 Billion Franchise

1 min read

Nearly two-thirds of patients who received Oruka Therapeutics' experimental psoriasis treatment had completely clear skin after 16 weeks.

Information in Investor’s Business Daily is for informational and educational purposes only and should not be construed as an offer, recommendation, solicitation, or rating to buy or sell securities. The information has been obtained from sources we ... [1013 chars]

Read Original Article

Source: Investor's Business Daily

Visit Source

Share this article